Why is Samrat Pharma falling/rising?

As of 22-Jul, Samrat Pharmachem Ltd's stock price is currently at Rs 370.00, reflecting a decrease of Rs 4.8 or 1.28%. The stock has underperformed its sector today by 0.37%, having touched an intraday low of Rs 366.2, which represents a decline of 2.29%. Over the past week, the stock has seen a slight decrease of 0.54%, while it has performed better over the past month with an increase of 8.50%. Despite a strong annual return of 8.47% and a significant profit increase of 229.2%, the stock's long-term growth prospects appear weak, with operating profit growing at only 8.89% annually over the last five years. Additionally, the company has reported poor quarterly results, including a significant drop in PAT and operating profit margins, which may be contributing to the current price decline.
In the broader market context, the Sensex has experienced a slight decline of 0.47% over the past week, indicating that the stock's short-term performance is somewhat in line with the market trend. However, the stock's year-to-date performance shows a decline of 3.15%, contrasting with the Sensex's gain of 5.18%. The falling investor participation, evidenced by a 28.3% drop in delivery volume compared to the five-day average, may also be impacting the stock's liquidity and overall market perception. Despite the company's high management efficiency and attractive valuation metrics, the combination of poor recent financial results and weak long-term growth prospects may be leading investors to reassess their positions, contributing to the stock's current downward movement.